EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2‐Positive Breast Cancer

Ningjun Duan iD, Yijia Hua, Xueqi Yan, Yaozhou He, Tianyu Zeng, Jue Gong, Ziyi Fu, Wei Li, Yongmei Yin iD

Advanced Science · 2024-05 · 11 (18)

DOI: 10.1002/advs.202309424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 09.03.2024. Verfasst von Ningjun Duan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of oncology, First affiliation hospital of Nanjing medical university, Nanjing, 210029, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Trastuzumab, Epigenesis, Genetic, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secondary trastuzumab resistance represents an evolutionary adaptation of HER2‐positive breast cancer during anti‐HER2 treatment. Most current studies have tended to prioritize HER2 and its associated signaling pathways, often overlooking broader but seemingly less relevant cellular processes, along with their associated genetic and epigenetic mechanisms. Here, transcriptome data is not only characterized but also examined epigenomic and 3D genome architecture information in both trastuzumab‐sensitive and secondary‐resistant breast cancer cells. The findings reveal that the global metabolic reprogramming associated with trastuzumab resistance may stem from genome‐wide alterations in both histone modifications and chromatin structure. Specifically, the transcriptional activities of key genes involved in lipid metabolism appear to be regulated by variant promoter H3K27me3 and H3K4me3 modifications, as well as promoter‐enhancer interactions. These discoveries offer valuable insights into how cancer cells adapt to anti‐tumor drugs and have the potential to impact future diagnostic and treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsTrastuzumabEpigenesis, GeneticErb-b2 Receptor Tyrosine KinasesChromatinLipid MetabolismHumansFemaleDrug Resistance, NeoplasmCell Line, TumorAntineoplastic Agents, ImmunologicalMetabolic Reprogramming

Stichwörter der Autor:innen

3D genome architecturebreast cancerhistone modificationmetabolic reprogrammingsecondary trastuzumab resistance

Substanzen

TrastuzumabErb-b2 Receptor Tyrosine KinasesChromatinAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of oncology, First affiliation hospital of Nanjing medical university, Nanjing, 210029, China.

ORCID-Profile: Ningjun Duan, Yongmei Yin

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Duan, N., Hua, Y., Yan, X., He, Y., Zeng, T., Gong, J., Fu, Z., Li, W., & Yin, Y. (2024). Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2‐Positive Breast Cancer. Advanced Science, 11(18). https://doi.org/10.1002/advs.202309424

Vancouver

Duan N, Hua Y, Yan X, He Y, Zeng T, Gong J, et al. Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2‐Positive Breast Cancer. Advanced Science. 2024;11(18). doi:10.1002/advs.202309424

BibTeX
@article{Duan2024,
  author = {Duan, Ningjun and Hua, Yijia and Yan, Xueqi and He, Yaozhou and Zeng, Tianyu and Gong, Jue and Fu, Ziyi and Li, Wei and Yin, Yongmei},
  title = {Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2‐Positive Breast Cancer},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {18},
  doi = {10.1002/advs.202309424}
}
Kostenlos starten →